Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway

Category Primary study
JournalJ. Med. Econ.
Year 2025
This article has no abstract
Epistemonikos ID: a945abf34de167e3de30e1b6eb480ec8aab09799
First added on: Mar 07, 2025